TScan Therapeutics, Inc. (TCRX) Earnings
|
Expand Research on TCRX
| Next EPS Date | 8/19/26 | EPS Growth Rate | +14.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q226 | N/A | -$0.24 | N/A | N/A | $1.88M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.22 | -$0.18 | -$0.04 | $1M | $2.5M | N/A |  | | Details | |
| 3/4/26 |
Q425 | -$0.18 | -$0.27 | +$0.09 | $2.57M | $2.04M | N/A | | | Details | |
| 11/12/25 | Q325 | -$0.28 | -$0.34 | +$0.06 | $2.51M | $1.31M | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | -$0.34 | N/A | N/A | $1.31M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.34 | N/A | N/A | $1.31M | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.34 | N/A | N/A | $1.31M | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.34 | N/A | N/A | $1.31M | N/A | N/A | N/A |
